Growth Hormone / Endocrine
Tesamorelin
FDA-approved GHRH analog (EGRIFTA WR), studied for pituitary GH release and clinically used to reduce visceral abdominal fat in HIV-associated lipodystrophy.
- Sources
- 7
- Last updated
- Jun · 2026
Side-by-side research summary. Tiers and mechanisms reflect the current state of the literature. No clinical advice.
FDA-approved GHRH analog (EGRIFTA WR), studied for pituitary GH release and clinically used to reduce visceral abdominal fat in HIV-associated lipodystrophy.
Synthetic 29 amino acid GHRH analog studied for pituitary growth hormone release, endocrine signaling, and age-associated GH decline.
Free Peptide Research Playbook on signup. No spam. Unsubscribe anytime.